Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3437]

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer...

Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )

Brigatinib for NSCLC, latest research and overcoming complications

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell...

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Update from KAITLIN for high-risk HER2-positive early breast cancer

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Update from KAITLIN for high-risk HER2-positive early breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA...

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative...

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )

COM701 as a monotherapy and in combination with nivolumab for various advanced...

Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )

Economic and research benefits of the AORTIC meeting

Prof Ahmed Elzawawy - Suez Canal University, Ismailia, Egypt

Economic and research benefits of the AORTIC meeting ( Prof Ahmed Elzawawy - Suez Canal University, Ismailia, Egypt )

Meet the Expert: Dr Bodour Salhia

Dr Bodour Salhia - University of Southern California, Los Angeles, USA

Meet the Expert: Dr Bodour Salhia ( Dr Bodour Salhia - University of Southern California, Los Angeles, USA )

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )

More from ecancer